We are live on ! Find out more
CAL

Capital Advisors Ltd Portfolio holdings

AUM $991M
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
-14.07%
1 Year Est. Return
+19.82%
3 Year Est. Return
+54.16%
5 Year Est. Return
+56.36%
10 Year Est. Return
+183.12%
AUM
$534M
AUM Growth
-$67.6M
Cap. Flow
+$21.6M
Cap. Flow %
4.04%
Top 10 Hldgs %
40.08%
Holding
1,474
New
353
Increased
398
Reduced
162
Closed
282

Sector Composition

Rank Sector Weight
1 Technology 2.45%
2 Consumer Discretionary 2.3%
3 Industrials 1.49%
4 Financials 1.28%
5 Healthcare 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POOL icon
1251
Pool Corp
POOL
$7B
-3
Closed -$1K
POWI icon
1252
Power Integrations
POWI
$3.3B
-13
Closed -$1K
PRI icon
1253
Primerica
PRI
$10B
$0 ﹤0.01%
+1
New +$126
PRLD icon
1254
Prelude Therapeutics
PRLD
$370M
$0 ﹤0.01%
+11
New +$56
PRO
1255
DELISTED
PROS Holdings
PRO
-13
Closed
PRPL icon
1256
Purple Innovation
PRPL
$35.7M
-4
Closed -$1K
PSMT icon
1257
Pricesmart
PSMT
$5.9B
-6
Closed
PSN icon
1258
Parsons
PSN
$6.64B
-25
Closed -$1K
QDEL icon
1259
QuidelOrtho
QDEL
$1.14B
$0 ﹤0.01%
3
QLYS icon
1260
Qualys
QLYS
$4.78B
-4
Closed -$1K
QNCX icon
1261
Quince Therapeutics
QNCX
$18.9M
0
QS icon
1262
QuantumScape Corp
QS
$3.18B
-22
Closed
RAMP icon
1263
LiveRamp
RAMP
$2.29B
$0 ﹤0.01%
+15
New +$445
RARE icon
1264
Ultragenyx Pharmaceutical
RARE
$2.56B
$0 ﹤0.01%
+5
New +$308
RBC icon
1265
RBC Bearings
RBC
$18.2B
$0 ﹤0.01%
+2
New +$355
REGN icon
1266
Regeneron Pharmaceuticals
REGN
$72.9B
-2
Closed -$1K
REYN icon
1267
Reynolds Consumer Products
REYN
$5.44B
$0 ﹤0.01%
12
-26
-68% -$728
REZI icon
1268
Resideo Technologies
REZI
$5.55B
$0 ﹤0.01%
7
-140
-95% -$3.16K
RF icon
1269
Regions Financial
RF
$26.7B
-33
Closed -$1K
RGA icon
1270
Reinsurance Group of America
RGA
$15.9B
-7
Closed -$1K
RGS icon
1271
Regis Corp
RGS
$68.2M
-30
Closed -$1K
RH icon
1272
RH
RH
$3.36B
$0 ﹤0.01%
+1
New +$297
RITM icon
1273
Rithm Capital
RITM
$5.46B
-10
Closed
RJF icon
1274
Raymond James Financial
RJF
$34B
-10
Closed -$1K
RLAY icon
1275
Relay Therapeutics
RLAY
$3.99B
-4
Closed

Similar funds

Capital Advisors Ltd's Q2 2022 Portfolio in Review

As of Q2 2022, Capital Advisors Ltd held 1,474 positions worth $534M, down 11% from $601M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Capital Advisors Ltd deployed $21.6M of net new capital in Q2 2022, opening 353 new positions and adding to 398 existing holdings. Its largest new stake was Bally's: 297,570 shares worth $5.89M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Schwab Fundamental US Large Company Index ETF, an estimated $1.02M trimmed.

  • Capital Advisors Ltd's largest Q2 2022 buy was Bally's: 297,570 shares worth $5.89M.
  • Capital Advisors Ltd added most to Schwab US Large- Cap ETF in Q2 2022, an estimated $1.06M increase.
  • Capital Advisors Ltd's biggest Q2 2022 reduction was Schwab Fundamental US Large Company Index ETF, cutting an estimated $1.02M.
  • Capital Advisors Ltd fully exited State Street SPDR Portfolio Emerging Markets ETF in Q2 2022, selling an estimated $248K.
  • Capital Advisors Ltd's ten largest holdings make up 40% of its $534M portfolio in Q2 2022.
  • Capital Advisors Ltd opened 353 new positions and closed 282 in Q2 2022.
  • Capital Advisors Ltd's portfolio value fell 11% quarter-over-quarter to $534M.

Based on Capital Advisors Ltd's 13F filing for Q2 2022, filed 5 Aug 2022.